These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27798205)

  • 21. Characteristics of Extended-Spectrum β-Lactamases-Producing Escherichia coli in Fecal Samples of Inpatients of Beijing Tongren Hospital.
    Xu M; Fan Y; Wang M; Lu X
    Jpn J Infect Dis; 2017 May; 70(3):290-294. PubMed ID: 27795466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.
    Adler A; Baraniak A; Izdebski R; Fiett J; Salvia A; Samso JV; Lawrence C; Solomon J; Paul M; Lerman Y; Schwartzberg Y; Mordechai E; Rossini A; Fierro J; Lammens C; Malhotra-Kumar S; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M; Carmeli Y;
    Clin Microbiol Infect; 2014 Aug; 20(8):O516-23. PubMed ID: 24450778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of ESBL-producing Escherichia coli from repeated prevalence studies over 11 years in a long-term-care facility.
    Martischang R; François P; Cherkaoui A; Gaïa N; Renzi G; Agostinho A; Perez M; Graf CE; Harbarth S
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):148. PubMed ID: 34666836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia.
    Ny S; Kozlov R; Dumpis U; Edquist P; Gröndahl-Yli-Hannuksela K; Kling AM; Lis DO; Lübbert C; Pomorska-Wesołowska M; Palagin I; Vilde A; Vuopio J; Walter J; Wisell KT;
    Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2347-2354. PubMed ID: 30338465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal carriage of extended-spectrum β-lactamase- and AmpC- producing Escherichia coli among healthcare workers.
    Bassyouni RH; Gaber SN; Wegdan AA
    J Infect Dev Ctries; 2015 Mar; 9(3):304-8. PubMed ID: 25771469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Cho SY; Kang CI; Cha MK; Wi YM; Ha YE; Chung DR; Lee NY; Peck KR; Song JH;
    Microb Drug Resist; 2015 Aug; 21(4):463-9. PubMed ID: 25756854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of the mcr-1 colistin resistance gene in extended-spectrum β-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China.
    Bi Z; Berglund B; Sun Q; Nilsson M; Chen B; Tärnberg M; Ding L; Stålsby Lundborg C; Bi Z; Tomson G; Yao J; Gu Z; Yin X; Kou Z; Nilsson LE
    Int J Antimicrob Agents; 2017 Apr; 49(4):493-497. PubMed ID: 28263896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caretaker knowledge, attitudes, and practices (KAP) and carriage of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) in children in Quito, Ecuador.
    Marusinec R; Kurowski KM; Amato HK; Saraiva-Garcia C; Loayza F; Salinas L; Trueba G; Graham JP
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):2. PubMed ID: 33407927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: Prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus.
    Maddox TW; Clegg PD; Diggle PJ; Wedley AL; Dawson S; Pinchbeck GL; Williams NJ
    Equine Vet J; 2012 May; 44(3):289-96. PubMed ID: 21848534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 2: Risk factors for faecal carriage of antimicrobial-resistant Escherichia coli in horses.
    Maddox TW; Pinchbeck GL; Clegg PD; Wedley AL; Dawson S; Williams NJ
    Equine Vet J; 2012 May; 44(3):297-303. PubMed ID: 21848536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on faecal carriage of ESBL-producing Enterobacteriaceae by Portuguese healthy humans: detection of the H30 subclone of B2-ST131 Escherichia coli producing CTX-M-27.
    Rodrigues C; Machado E; Fernandes S; Peixe L; Novais Â
    J Antimicrob Chemother; 2016 Apr; 71(4):1120-2. PubMed ID: 26747102
    [No Abstract]   [Full Text] [Related]  

  • 39. Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Madigan T; Johnson JR; Clabots C; Johnston BD; Porter SB; Slater BS; Banerjee R
    Clin Infect Dis; 2015 Jul; 61(1):e5-12. PubMed ID: 25828998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Cross-Sectional Cohort Study of Extended-Spectrum-Beta-Lactamase-Producing
    Ljungquist O; Camporeale A; Nematzadeh S; Giske CG; Resman F; Riesbeck K; Tham J
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.